Results 41 to 50 of about 281,327 (265)

Effect size of lithium, carbamazepine, and sodium valproate in child and adolescent bipolar 1 disorder during manic phase: A prospective open-label study

open access: yesIndustrial Psychiatry Journal, 2019
Aim: The aim was to evaluate the “effect size (ES),” tolerability, and acceptability of lithium, carbamazepine, and sodium valproate in the acute phase treatment of pediatric Bipolar 1 disorder patients during manic phase.
Rakesh Kumar Singh   +2 more
doaj   +1 more source

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: An Overview

open access: yesPharmaceuticals, 2020
Patients with hepatocellular carcinoma (HCC) face a common type of cancer, which is amongst the most deadly types of cancer worldwide. The therapeutic options range from curative resection or ablation to loco regional therapies in palliative setting and ...
Diederick J. van Doorn   +2 more
doaj   +1 more source

Summary of local tolerability parameters.

open access: yes, 2016
Summary of local tolerability parameters.
Bart Rossel (2827424)   +4 more
core   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan   +5 more
wiley   +1 more source

Angiotensin receptor blockers in heart failure after the ELITE II trial

open access: yesCurrent Controlled Trials in Cardiovascular Medicine, 2000
Specific blockers of the angiotensin type1 receptor, angiotensin receptor blockers (ARBs), have been introduced as an alternative to angiotensin-converting enzyme inhibitors (ACEi) for the treatment of heart failure.
Willenheimer Ronnie
doaj   +1 more source

Safety and tolerability of antipsychotics: focus on amisulpride

open access: yes, 2010
Mario F Juruena1, Eduardo Pondé de Sena2, Irismar Reis de Oliveira31Stress and Affective Disorders Programme, Department of Neuroscience and Behaviour, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, Sao Paulo, Brazil ...
de Oliveira, Irismar Reis   +7 more
core   +1 more source

Safety and Tolerability of Givinostat: Evidence From Real‐World and Clinical Practice

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The aim of our study was to establish the prevalence of adverse events in a real‐world setting in boys living with Duchenne muscular dystrophy (DMD) treated with givinostat as part of an Expanded Access Program (EAP) in Italy. Methods The cohort included 90 ambulant boys, with age when treatment started between 6 and 23 years (mean ...
Marika Pane   +19 more
wiley   +1 more source

Tolerability of boceprevir and telaprevir.

open access: yes, 2016
Tolerability of boceprevir and telaprevir.
Yngve Falck-Ytter (835658)   +9 more
core   +1 more source

Place of Voltaren in clinical practice: emphasis on its tolerability [PDF]

open access: yes, 2009
The paper considers the tolerability of Voltaren versus other nonsteroidal anti-inflammatory drugs, including generics. A wealth of clinical experience in using Voltaren leads to the conclusion on its good tolerability and significant anti-inflammatory ...
G R Imametdinova, N V Chichasova
core   +1 more source

Long‐Term Efficacy of Immunotherapy in Autoimmune Autonomic Ganglionopathy—A 10‐Year Follow Up Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Autoimmune autonomic ganglionopathy (AAG) is a rare but potentially treatable cause of severe autonomic failure. Evidence guiding long‐term immunotherapy, treatment sequencing, and residual autonomic impairment is limited. We evaluated long‐term treatment response, residual autonomic dysfunction, and relapse patterns in patients with
Giacomo Chiaro   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy